Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial

Luis G Paz-Ares, Filippo de Marinis, Mircea Dediu et al. · The Lancet Oncology · 2012

Cited by 609 works. doi:10.1016/s1470-2045(12)70063-3

Authors

References